title: Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor-treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.
authors.affiliation: Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA. jashinwu@hotmail.com.
authors.forename: Jashin J
authors.initials: JJ
authors.lastname: Wu
authors.affiliation: American Medical Group Association, Alexandria, VA, USA.
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Rowan
authors.affiliation: Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
authors.forename: Judith D
authors.initials: JD
authors.lastname: Bebchuk
authors.affiliation: RTI Health Solutions, Durham, NC, USA.
authors.forename: Mary S
authors.initials: MS
authors.lastname: Anthony
mesh_terms: D015535:Arthritis, Psoriatic / Q000097:blood* / Q000188:drug therapy*; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008727:Methotrexate / Q000627:therapeutic use; D011565:Psoriasis / Q000097:blood / Q000188:drug therapy; D012189:Retrospective Studies; D014280:Triglycerides / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D007166:Immunosuppressive Agents; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D014280:Triglycerides; D014409:Tumor Necrosis Factor-alpha; D002784:Cholesterol; D008727:Methotrexate